Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee

Stuart G Tangye 1 2, Waleed Al-Herz 3, Aziz Bousfiha 4, Charlotte Cunningham-Rundles 5, Jose Luis Franco 6, Steven M Holland 7, Christoph Klein 8, Tomohiro Morio 9, Eric Oksenhendler 10, Capucine Picard 11 12, Anne Puel 13 14, Jennifer Puck 15, Mikko R J Seppänen 16, Raz Somech 17, Helen C Su 7, Kathleen E Sullivan 18, Troy R Torgerson 19, Isabelle Meyts 20

Affiliations

01 October 2022

-

doi: 10.1007/s10875-022-01289-3

Abstract

We report the updated classification of inborn errors of immunity, compiled by the International Union of Immunological Societies Expert Committee. This report documents the key clinical and laboratory features of 55 novel monogenic gene defects, and 1 phenocopy due to autoantibodies, that have either been discovered since the previous update (published January 2020) or were characterized earlier but have since been confirmed or expanded in subsequent studies. While variants in additional genes associated with immune diseases have been reported in the literature, this update includes only those that the committee assessed that reached the necessary threshold to represent novel inborn errors of immunity. There are now a total of 485 inborn errors of immunity. These advances in discovering the genetic causes of human immune diseases continue to significantly further our understanding of molecular, cellular, and immunological mechanisms of disease pathogenesis, thereby simultaneously enhancing immunological knowledge and improving patient diagnosis and management. This report is designed to serve as a resource for immunologists and geneticists pursuing the molecular diagnosis of individuals with heritable immunological disorders and for the scientific dissection of cellular and molecular mechanisms underlying monogenic and related human immune diseases.

Keywords: IUIS Committee update; Inborn errors of immunity; autoinflammatory disorders; immune dysregulation; primary immunodeficiencies.

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1 Accumulative discovery of novel inborn errors of immunity: 1980–2022. (A) The number of genetic defects underlying monogenic immune disorders as reported in the indicated year. (B) The number of pathogenic variants listed in each Table of the IUIS IEI committee 2022 report. The numbers in each column correspond to the number of genes reported in the 2019 IUIS update (blue bars) [4, 5], the number of new genes for each Table contained in this report (red bars), and the total number of genes for each Table (black number). Note: The 14 conditions listed for Table 10 are either phenocopies of germline IEI due to somatic variants or neutralizing autoAbs. Somatic variants in UBA1 are also listed in Table 10, although there is currently no IEI resulting from germline UBA1 variants [97]

Fig. 1 Accumulative discovery of novel inborn errors of immunity: 1980–2022. (A) The number of genetic defects underlying monogenic immune disorders as reported in the indicated year. (B) The number of pathogenic variants listed in each Table of the IUIS IEI committee 2022 report. The numbers in each column correspond to the number of genes reported in the 2019 IUIS update (blue bars) [4, 5], the number of new genes for each Table contained in this report (red bars), and the total number of genes for each Table (black number). Note: The 14 conditions listed for Table 10 are either phenocopies of germline IEI due to somatic variants or neutralizing autoAbs. Somatic variants in UBA1 are also listed in Table 10, although there is currently no IEI resulting from germline UBA1 variants [97]

Similar articles

Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, Ochs HD, Oksenhendler E, Picard C, Puck J, Torgerson TR, Casanova JL, Sullivan KE.J Clin Immunol. 2020 Jan;40(1):24-64. doi: 10.1007/s10875-019-00737-x. Epub 2020 Jan 17.PMID: 31953710 Free PMC article.

The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity.

Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, Rundles CC, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Puel A, Puck J, Seppänen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I.J Clin Immunol. 2022 Oct;42(7):1508-1520. doi: 10.1007/s10875-022-01352-z. Epub 2022 Oct 6.PMID: 36198931

The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee.

Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, Klein C, Morio T, Oksenhendler E, Picard C, Puel A, Puck J, Seppänen MRJ, Somech R, Su HC, Sullivan KE, Torgerson TR, Meyts I.J Clin Immunol. 2021 Apr;41(3):666-679. doi: 10.1007/s10875-021-00980-1. Epub 2021 Feb 18.PMID: 33598806 Free PMC article. Review.

Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.

Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, Ochs HD, Oksenhendler E, Puck J, Torgerson TR, Casanova JL, Sullivan KE, Tangye SG.J Clin Immunol. 2020 Jan;40(1):66-81. doi: 10.1007/s10875-020-00758-x. Epub 2020 Feb 11.PMID: 32048120 Free PMC article.

Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015.

Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, Etzioni A, Holland SM, Klein C, Nonoyama S, Ochs HD, Oksenhendler E, Puck JM, Sullivan KE, Tang ML, Franco JL, Gaspar HB.J Clin Immunol. 2015 Nov;35(8):696-726. doi: 10.1007/s10875-015-0201-1. Epub 2015 Oct 19.PMID: 26482257 Free PMC article. Review.

Cited by

Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies.

Lucane Z, Slisere B, Gersone G, Papirte S, Gailite L, Tretjakovs P, Kurjane N.Viruses. 2023 May 10;15(5):1146. doi: 10.3390/v15051146.PMID: 37243231 Free PMC article.

Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi-Fujimoto disease: a rare Palestinian case report.

Abulaila KJ, Sabha MA, Misk MR, Alhalabeye AA, Jobran AWM, Abunejma FM, Bakri IA.Ann Med Surg (Lond). 2023 Apr 7;85(5):2064-2067. doi: 10.1097/MS9.0000000000000476. eCollection 2023 May.PMID: 37229047 Free PMC article.

Detection of specific RBD+ IgG+ memory B cells by flow cytometry in healthcare workers and patients with inborn errors of immunity after BNT162b2 m RNA COVID-19 vaccination.

Del Pino Molina L, Bravo Gallego LY, Nozal P, Soto-Serrano Y, Martínez-Feito A, Reche-Yebra K, González-Torbay A, Cuesta-Martín de la Cámara R, Gianelli C, Cámara C, González-García J, González-Muñoz M, Rodríguez-Pena R, López Granados E.Front Immunol. 2023 May 4;14:1136308. doi: 10.3389/fimmu.2023.1136308. eCollection 2023.PMID: 37215146 Free PMC article.

Chromosomal microarray analysis supplements exome sequencing to diagnose children with suspected inborn errors of immunity.

Beers BJ, Similuk MN, Ghosh R, Seifert BA, Jamal L, Kamen M, Setzer MR, Jodarski C, Duncan R, Hunt D, Mixer M, Cao W, Bi W, Veltri D, Karlins E, Zhang L, Li Z, Oler AJ, Jevtich K, Yu Y, Hullfish H, Bielekova B, Frischmeyer-Guerrerio P, Dang Do A, Huryn LA, Olivier KN, Su HC, Lyons JJ, Zerbe CS, Rao VK, Keller MD, Freeman AF, Holland SM, Franco LM, Walkiewicz MA, Yan J.Front Immunol. 2023 May 5;14:1172004. doi: 10.3389/fimmu.2023.1172004. eCollection 2023.PMID: 37215141 Free PMC article.

Monogenic inborn errors of immunity in autoimmune disorders.

Venkatachari IV, Chougule A, Gowri V, Taur P, Bodhanwala M, Prabhu S, Madkaikar M, Desai M.Immunol Res. 2023 May 18. doi: 10.1007/s12026-023-09391-3. Online ahead of print.PMID: 37199901

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Zhang Q, Frange P, Blanche S, Casanova JL. Pathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies. Curr Opin Immunol. 2017;48:122–133. doi: 10.1016/j.coi.2017.09.002. - DOI - PMC - PubMed
  2.  
    1. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128. doi: 10.1007/s10875-017-0464-9. - DOI - PMC - PubMed
  3.  
    1. Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, Al-Herz W, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018;38(1):129–143. doi: 10.1007/s10875-017-0465-8. - DOI - PMC - PubMed
  4.  
    1. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40(1):66–81. doi: 10.1007/s10875-020-00758-x. - DOI - PMC - PubMed
  5.  
    1. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64. doi: 10.1007/s10875-019-00737-x. - DOI - PMC - PubMed
  6.  
    1. Casanova JL, Abel L. Human genetics of infectious diseases: unique insights into immunological redundancy. Semin Immunol. 2018;36:1–12. doi: 10.1016/j.smim.2017.12.008. - DOI - PMC - PubMed
  7.  
    1. Fischer A, Rausell A. What do primary immunodeficiencies tell us about the essentiality/redundancy of immune responses? Semin Immunol. 2018;36:13–16. doi: 10.1016/j.smim.2017.12.001. - DOI - PubMed
  8.  
    1. Picard C, Fischer A. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur J Immunol. 2014;44(10):2854–2861. doi: 10.1002/eji.201444669. - DOI - PubMed
  9.  
    1. Leiding JW, Forbes LR. Mechanism-based precision therapy for the treatment of primary immunodeficiency and primary immunodysregulatory diseases. J Allergy Clin Immunol Pract. 2019;7(3):761–773. doi: 10.1016/j.jaip.2018.12.017. - DOI - PubMed
  10.  
    1. Ma CS, Tangye SG. Flow cytometric-based analysis of defects in lymphocyte differentiation and function due to inborn errors of immunity. Front Immunol. 2019;10:2108. doi: 10.3389/fimmu.2019.02108. - DOI - PMC - PubMed
  11.  
    1. Casanova JL, Conley ME, Seligman SJ, Abel L, Notarangelo LD. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med. 2014;211(11):2137–2149. doi: 10.1084/jem.20140520. - DOI - PMC - PubMed
  12.  
    1. Lev A, Lee YN, Sun G, Hallumi E, Simon AJ, Zrihen KS, et al. Inherited SLP76 deficiency in humans causes severe combined immunodeficiency, neutrophil and platelet defects. J Exp Med. 2021;218(3). 10.1084/jem.20201062. - PMC - PubMed
  13.  
    1. Yamazaki Y, Urrutia R, Franco LM, Giliani S, Zhang K, Alazami AM, et al. PAX1 is essential for development and function of the human thymus. Sci Immunol. 2020;5(44). 10.1126/sciimmunol.aax1036. - PMC - PubMed
  14.  
    1. Paganini I, Sestini R, Capone GL, Putignano AL, Contini E, Giotti I, et al. A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency. Clin Genet. 2017;92(6):664–668. doi: 10.1111/cge.13085. - DOI - PubMed
  15.  
    1. Almutairi A, Wallace JG, Jaber F, Alosaimi MF, Jones J, Sallam MTH, et al. Severe combined immunodeficiency caused by inositol-trisphosphate 3-kinase B (ITPKB) deficiency. J Allergy Clin Immunol. 2020. 10.1016/j.jaci.2020.01.014. - PubMed
  16.  
    1. Delmonte OM, Bergerson JRE, Kawai T, Kuehn HS, McDermott DH, Cortese I, et al. SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation. Blood. 2021;138(12):1019–1033. doi: 10.1182/blood.2020008629. - DOI - PMC - PubMed
  17.  
    1. Labrador-Horrillo M, Franco-Jarava C, Garcia-Prat M, Parra-Martinez A, Antolin M, Salgado-Perandres S, et al. Case report: X-Linked SASH3 deficiency presenting as a common variable immunodeficiency. Front Immunol. 2022;13:881206. doi: 10.3389/fimmu.2022.881206. - DOI - PMC - PubMed
  18.  
    1. Verheijen J, Wong SY, Rowe JH, Raymond K, Stoddard J, Delmonte OM, et al. Defining a new immune deficiency syndrome: MAN2B2-CDG. J Allergy Clin Immunol. 2020;145(3):1008–1011. doi: 10.1016/j.jaci.2019.11.016. - DOI - PMC - PubMed
  19.  
    1. Bainter W, Platt CD, Park SY, Stafstrom K, Wallace JG, Peters ZT, et al. Combined immunodeficiency due to a mutation in the gamma1 subunit of the coat protein I complex. J Clin Invest. 2021;131(3). 10.1172/JCI140494. - PMC - PubMed
  20.  
    1. Hetemaki I, Kaustio M, Kinnunen M, Heikkila N, Keskitalo S, Nowlan K, et al. Loss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells. Sci Immunol. 2021;6(65):eabe3454. doi: 10.1126/sciimmunol.abe3454. - DOI - PubMed
  21.  
    1. Shahin T, Kuehn HS, Shoeb MR, Gawriyski L, Giuliani S, Repiscak P, et al. Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity. Sci Immunol. 2021;6(65):eabe3981. doi: 10.1126/sciimmunol.abe3981. - DOI - PMC - PubMed
  22.  
    1. Hadjadj J, Aladjidi N, Fernandes H, Leverger G, Magerus-Chatinet A, Mazerolles F, et al. Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. 2019;134(1):9–21. doi: 10.1182/blood-2018-11-887141. - DOI - PubMed
  23.  
    1. Shahin T, Mayr D, Shoeb MR, Kuehn HS, Hoeger B, Giuliani S, et al. Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation. Blood Adv. 2021. 10.1182/bloodadvances.2021006367. - PMC - PubMed
  24.  
    1. Bainter W, Lougaris V, Wallace JG, Badran Y, Hoyos-Bachiloglu R, Peters Z, et al. Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor B kinase alpha (IKKalpha) Sci Immunol. 2021;6(63):eabf6723. doi: 10.1126/sciimmunol.abf6723. - DOI - PMC - PubMed
  25.  
    1. Yamashita M, Kuehn HS, Okuyama K, Okada S, Inoue Y, Mitsuiki N, et al. A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS. Nat Immunol. 2021;22(7):893–903. doi: 10.1038/s41590-021-00951-z. - DOI - PMC - PubMed
  26.  
    1. Kuehn HS, Chang J, Yamashita M, Niemela JE, Zou C, Okuyama K, et al. T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients. J Exp Med. 2021;218(12). 10.1084/jem.20211118. - PMC - PubMed
  27.  
    1. Wu B, Rice L, Shrimpton J, Lawless D, Walker K, Carter C, et al. Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder. Elife. 2021;10. 10.7554/eLife.72559. - PMC - PubMed
  28.  
    1. Beziat V, Rapaport F, Hu J, Titeux M, Bonnet des Claustres M, Bourgey M et al. Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy. Cell. 2021;184(14):3812-28 e30. doi:10.1016/j.cell.2021.06.004. - PMC - PubMed
  29.  
    1. Mace EM, Paust S, Conte MI, Baxley RM, Schmit MM, Patil SL, et al. Human NK cell deficiency as a result of biallelic mutations in MCM10. J Clin Invest. 2020. 10.1172/JCI134966. - PMC - PubMed
  30.  
    1. Baxley RM, Leung W, Schmit MM, Matson JP, Yin L, Oram MK, et al. Bi-allelic MCM10 variants associated with immune dysfunction and cardiomyopathy cause telomere shortening. Nat Commun. 2021;12(1):1626. doi: 10.1038/s41467-021-21878-x. - DOI - PMC - PubMed
  31.  
    1. Beziat V, Tavernier SJ, Chen YH, Ma CS, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217(6). 10.1084/jem.20191804. - PMC - PubMed
  32.  
    1. Monies D, Abouelhoda M, Assoum M, Moghrabi N, Rafiullah R, Almontashiri N, et al. Lessons learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population. Am J Hum Genet. 2019;104(6):1182–1201. doi: 10.1016/j.ajhg.2019.04.011. - DOI - PMC - PubMed
  33.  
    1. Chen YH, Grigelioniene G, Newton PT, Gullander J, Elfving M, Hammarsjo A, et al. Absence of GP130 cytokine receptor signaling causes extended Stuve-Wiedemann syndrome. J Exp Med. 2020;217(3). 10.1084/jem.20191306. - PMC - PubMed
  34.  
    1. Kaustio M, Nayebzadeh N, Hinttala R, Tapiainen T, Astrom P, Mamia K, et al. Loss of DIAPH1 causes SCBMS, combined immunodeficiency, and mitochondrial dysfunction. J Allergy Clin Immunol. 2021;148(2):599–611. doi: 10.1016/j.jaci.2020.12.656. - DOI - PubMed
  35.  
    1. Niehues T, Ozgur TT, Bickes M, Waldmann R, Schoning J, Brasen J, et al. Mutations of the gene FNIP1 associated with a syndromic autosomal recessive immunodeficiency with cardiomyopathy and pre-excitation syndrome. Eur J Immunol. 2020;50(7):1078–1080. doi: 10.1002/eji.201948504. - DOI - PubMed
  36.  
    1. Saettini F, Poli C, Vengoechea J, Bonanomi S, Orellana JC, Fazio G, et al. Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin interacting protein 1 deficiency. Blood. 2020. 10.1182/blood.2020006441. - PMC - PubMed
  37.  
    1. Le Coz C, Nguyen DN, Su C, Nolan BE, Albrecht AV, Xhani S, et al. Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients. J Exp Med. 2021;218(7). 10.1084/jem.20201750. - PMC - PubMed
  38.  
    1. Takeda AJ, Maher TJ, Zhang Y, Lanahan SM, Bucklin ML, Compton SR, et al. Human PI3Kgamma deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology. Nat Commun. 2019;10(1):4364. doi: 10.1038/s41467-019-12311-5. - DOI - PMC - PubMed
  39.  
    1. Thian M, Hoeger B, Kamnev A, Poyer F, Kostel Bal S, Caldera M, et al. Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation. Haematologica. 2020. 10.3324/haematol.2019.231399. - PMC - PubMed
  40.  
    1. Kury P, Staniek J, Wegehaupt O, Janowska I, Eckenweiler M, Korinthenberg R, et al. Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1. J Allergy Clin Immunol. 2021;147(5):1977–1980. doi: 10.1016/j.jaci.2021.01.027. - DOI - PubMed
  41.  
    1. Kuhny M, Forbes LR, Cakan E, Vega-Loza A, Kostiuk V, Dinesh RK, et al. Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID. J Clin Invest. 2020. 10.1172/JCI131297. - PMC - PubMed
  42.  
    1. Yeh TW, Okano T, Naruto T, Yamashita M, Okamura M, Tanita K, et al. APRIL-dependent life-long plasmacyte maintenance and immunoglobulin production in humans. J Allergy Clin Immunol. 2020. 10.1016/j.jaci.2020.03.025. - PubMed
  43.  
    1. Kalinichenko A, Perinetti Casoni G, Dupre L, Trotta L, Huemer J, Galgano D, et al. RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosis. Blood. 2021;137(15):2033–2045. doi: 10.1182/blood.2020008738. - DOI - PMC - PubMed
  44.  
    1. Lee PY, Platt CD, Weeks S, Grace RF, Maher G, Gauthier K, et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol. 2020. 10.1016/j.jaci.2020.07.033. - PMC - PubMed
  45.  
    1. Thaventhiran JED, Lango Allen H, Burren OS, Rae W, Greene D, Staples E, et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature. 2020;583(7814):90–95. doi: 10.1038/s41586-020-2265-1. - DOI - PMC - PubMed
  46.  
    1. Hadjadj J, Castro CN, Tusseau M, Stolzenberg MC, Mazerolles F, Aladjidi N, et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun. 2020;11(1):5341. doi: 10.1038/s41467-020-18925-4. - DOI - PMC - PubMed
  47.  
    1. Ogishi M, Yang R, Aytekin C, Langlais D, Bourgey M, Khan T, et al. Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child. Nat Med. 2021;27(9):1646–1654. doi: 10.1038/s41591-021-01388-5. - DOI - PMC - PubMed
  48.  
    1. Tyler PM, Bucklin ML, Zhao M, Maher TJ, Rice AJ, Ji W, et al. Human autoinflammatory disease reveals ELF4 as a transcriptional regulator of inflammation. Nat Immunol. 2021;22(9):1118–1126. doi: 10.1038/s41590-021-00984-4. - DOI - PMC - PubMed
  49.  
    1. Sun G, Qiu L, Yu L, An Y, Ding Y, Zhou L, et al. Loss of function mutation in ELF4 causes autoinflammatory and immunodeficiency disease in human. J Clin Immunol. 2022. 10.1007/s10875-022-01243-3. - PubMed
  50.  
    1. Stremenova Spegarova J, Lawless D, Mohamad SMB, Engelhardt KR, Doody G, Shrimpton J, et al. Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. Blood. 2020;136(9):1055–1066. doi: 10.1182/blood.2020005844. - DOI - PubMed
  51.  
    1. Goos H, Fogarty CL, Sahu B, Plagnol V, Rajamaki K, Nurmi K, et al. Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy. J Allergy Clin Immunol. 2019;144(5):1364–1376. doi: 10.1016/j.jaci.2019.06.003. - DOI - PubMed
  52.  
    1. Hoshino A, Boutboul D, Zhang Y, Kuehn HS, Hadjadj J, Ozdemir N, et al. Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation. Sci Immunol. 2022;7(69):eabi7160. doi: 10.1126/sciimmunol.abi7160. - DOI - PubMed
  53.  
    1. Marin-Esteban V, Youn J, Beaupain B, Jaracz-Ros A, Barlogis V, Fenneteau O, et al. Biallelic CXCR2 loss-of-function mutations define a distinct congenital neutropenia entity. Haematologica. 2021. 10.3324/haematol.2021.279254. - PMC - PubMed
  54.  
    1. Auer PL, Teumer A, Schick U, O’Shaughnessy A, Lo KS, Chami N, et al. Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits. Nat Genet. 2014;46(6):629–634. doi: 10.1038/ng.2962. - DOI - PMC - PubMed
  55.  
    1. Yang R, Mele F, Worley L, Langlais D, Rosain J, Benhsaien I, et al. Human T-bet governs innate and innate-like adaptive IFN-gamma immunity against mycobacteria. Cell. 2020;183(7):1826–47 e31. doi: 10.1016/j.cell.2020.10.046. - DOI - PMC - PubMed
  56.  
    1. Yang R, Weisshaar M, Mele F, Benhsaien I, Dorgham K, Han J, et al. High Th2 cytokine levels and upper airway inflammation in human inherited T-bet deficiency. J Exp Med. 2021;218(8). 10.1084/jem.20202726. - PMC - PubMed
  57.  
    1. Kerner G, Rosain J, Guerin A, AlKhabaz A, Oleaga-Quintas C, Rapaport F, et al. Inherited human IFNgamma deficiency underlies mycobacterial disease. J Clin Invest. 2020. 10.1172/JCI135460. - PMC - PubMed
  58.  
    1. Aluri J, Bach A, Kaviany S, Chiquetto Paracatu L, Kitcharoensakkul M, Walkiewicz MA, et al. Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function. Blood. 2021;137(18):2450–2462. doi: 10.1182/blood.2020009620. - DOI - PMC - PubMed
  59.  
    1. Fejtkova M, Sukova M, Hlozkova K, Skvarova Kramarzova K, Rackova M, Jakubec D, et al. TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins. Am J Hematol. 2022;97(3):338–351. doi: 10.1002/ajh.26452. - DOI - PubMed
  60.  
    1. Drutman SB, Mansouri D, Mahdaviani SA, Neehus AL, Hum D, Bryk R, et al. Fatal cytomegalovirus infection in an adult with inherited NOS2 deficiency. N Engl J Med. 2020;382(5):437–445. doi: 10.1056/NEJMoa1910640. - DOI - PMC - PubMed
  61.  
    1. Lafaille FG, Harschnitz O, Lee YS, Zhang P, Hasek ML, Kerner G, et al. Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis. Nat Med. 2019;25(12):1873–1884. doi: 10.1038/s41591-019-0672-3. - DOI - PMC - PubMed
  62.  
    1. Hait AS, Olagnier D, Sancho-Shimizu V, Skipper KA, Helleberg M, Larsen SM, et al. Defects in LC3B2 and ATG4A underlie HSV2 meningitis and reveal a critical role for autophagy in antiviral defense in humans. Sci Immunol. 2020;5(54). 10.1126/sciimmunol.abc2691. - PMC - PubMed
  63.  
    1. Vavassori S, Chou J, Faletti LE, Haunerdinger V, Opitz L, Joset P, et al. Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency. J Allergy Clin Immunol. 2021;148(2):381–393. doi: 10.1016/j.jaci.2021.03.045. - DOI - PMC - PubMed
  64.  
    1. Le Voyer T, Neehus AL, Yang R, Ogishi M, Rosain J, Alroqi F, et al. Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease. Proc Natl Acad Sci U S A. 2021;118(15). 10.1073/pnas.2102804118. - PMC - PubMed
  65.  
    1. Alawbathani S, Westenberger A, Ordonez-Herrera N, Al-Hilali M, Al Hebby H, Alabbas F, et al. Biallelic ZNFX1 variants are associated with a spectrum of immuno-hematological abnormalities. Clin Genet. 2022;101(2):247–254. doi: 10.1111/cge.14081. - DOI - PubMed
  66.  
    1. Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, et al. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021;6(62). 10.1126/sciimmunol.abl4348. - PMC - PubMed
  67.  
    1. van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al. Presence of genetic variants among young men with severe COVID-19. JAMA. 2020;324(7):663–673. doi: 10.1001/jama.2020.13719. - DOI - PMC - PubMed
  68.  
    1. Abolhassani H, Vosughimotlagh A, Asano T, Landegren N, Boisson B, Delavari S, et al. X-linked TLR7 deficiency underlies critical COVID-19 pneumonia in a male patient with ataxia-telangiectasia. J Clin Immunol. 2021. 10.1007/s10875-021-01151-y. - PMC - PubMed
  69.  
    1. Li J, Ritelli M, Ma CS, Rao G, Habib T, Corvilain E, et al. Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-beta. Sci Immunol. 2019;4(41). 10.1126/sciimmunol.aax7965. - PMC - PubMed
  70.  
    1. Lin B, Berard R, Al Rasheed A, Aladba B, Kranzusch PJ, Henderlight M, et al. A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI) J Allergy Clin Immunol. 2020;146(5):1204–8 e6. doi: 10.1016/j.jaci.2020.06.032. - DOI - PMC - PubMed
  71.  
    1. Uggenti C, Lepelley A, Depp M, Badrock AP, Rodero MP, El-Daher MT, et al. cGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing. Nat Genet. 2020;52(12):1364–1372. doi: 10.1038/s41588-020-00737-3. - DOI - PubMed
  72.  
    1. Verboon JM, Mahmut D, Kim AR, Nakamura M, Abdulhay NJ, Nandakumar SK, et al. Infantile myelofibrosis and myeloproliferation with CDC42 dysfunction. J Clin Immunol. 2020. 10.1007/s10875-020-00778-7. - PMC - PubMed
  73.  
    1. Lam MT, Coppola S, Krumbach OHF, Prencipe G, Insalaco A, Cifaldi C, et al. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function. J Exp Med. 2019;216(12):2778–2799. doi: 10.1084/jem.20190147. - DOI - PMC - PubMed
  74.  
    1. Gernez Y, de Jesus AA, Alsaleem H, Macaubas C, Roy A, Lovell D, et al. Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1beta inhibition. J Allergy Clin Immunol. 2019;144(4):1122–5 e6. doi: 10.1016/j.jaci.2019.06.017. - DOI - PMC - PubMed
  75.  
    1. Bucciol G, Pillay B, Casas-Martin J, Delafontaine S, Proesmans M, Lorent N, et al. Systemic inflammation and myelofibrosis in a patient with Takenouchi-Kosaki syndrome due to CDC42 Tyr64Cys mutation. J Clin Immunol. 2020. 10.1007/s10875-020-00742-5. - PubMed
  76.  
    1. Bekhouche B, Tourville A, Ravichandran Y, Tacine R, Abrami L, Dussiot M, et al. A toxic palmitoylation of Cdc42 enhances NF-kappaB signaling and drives a severe autoinflammatory syndrome. J Allergy Clin Immunol. 2020. 10.1016/j.jaci.2020.03.020. - PubMed
  77.  
    1. He T, Huang Y, Ling J, Yang J. A new patient with NOCARH syndrome due to CDC42 defect. J Clin Immunol. 2020;40(4):571–575. doi: 10.1007/s10875-020-00786-7. - DOI - PubMed
  78.  
    1. Szczawinska-Poplonyk A, Ploski R, Bernatowska E, Pac M. A novel CDC42 mutation in an 11-year old child manifesting as syndromic immunodeficiency, autoinflammation, hemophagocytic lymphohistiocytosis, and malignancy: a case report. Front Immunol. 2020;11:318. doi: 10.3389/fimmu.2020.00318. - DOI - PMC - PubMed
  79.  
    1. Duncan CJA, Thompson BJ, Chen R, Rice GI, Gothe F, Young DF et al. Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2. Sci Immunol 2019;4(42). 10.1126/sciimmunol.aav7501. - PMC - PubMed
  80.  
    1. Gruber C, Martin-Fernandez M, Ailal F, Qiu X, Taft J, Altman J, et al. Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy. J Exp Med. 2020;217(5). 10.1084/jem.20192319. - PMC - PubMed
  81.  
    1. Lepelley A, Della Mina E, Van Nieuwenhove E, Waumans L, Fraitag S, Rice GI, et al. Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A. J Exp Med. 2021;218(10). 10.1084/jem.20201560. - PMC - PubMed
  82.  
    1. Taft J, Markson M, Legarda D, Patel R, Chan M, Malle L, et al. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death. Cell. 2021;184(17):4447–63 e20. doi: 10.1016/j.cell.2021.07.026. - DOI - PMC - PubMed
  83.  
    1. Wong HH, Seet SH, Maier M, Gurel A, Traspas RM, Lee C, et al. Loss of C2orf69 defines a fatal autoinflammatory syndrome in humans and zebrafish that evokes a glycogen-storage-associated mitochondriopathy. Am J Hum Genet. 2021;108(7):1301–1317. doi: 10.1016/j.ajhg.2021.05.003. - DOI - PMC - PubMed
  84.  
    1. Lausberg E, Giesselmann S, Dewulf JP, Wiame E, Holz A, Salvarinova R, et al. C2orf69 mutations disrupt mitochondrial function and cause a multisystem human disorder with recurring autoinflammation. J Clin Invest. 2021;131(12). 10.1172/JCI143078. - PMC - PubMed
  85.  
    1. Tao P, Sun J, Wu Z, Wang S, Wang J, Li W, et al. A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature. 2020;577(7788):109–114. doi: 10.1038/s41586-019-1830-y. - DOI - PubMed
  86.  
    1. Lalaoui N, Boyden SE, Oda H, Wood GM, Stone DL, Chau D, et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature. 2020;577(7788):103–108. doi: 10.1038/s41586-019-1828-5. - DOI - PMC - PubMed
  87.  
    1. Cook SA, Comrie WA, Poli MC, Similuk M, Oler AJ, Faruqi AJ, et al. HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science. 2020;369(6500):202–207. doi: 10.1126/science.aay5663. - DOI - PMC - PubMed
  88.  
    1. Salzer E, Zoghi S, Kiss MG, Kage F, Rashkova C, Stahnke S, et al. The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunity. Sci Immunol. 2020;5(49). 10.1126/sciimmunol.abc3979. - PMC - PubMed
  89.  
    1. Castro CN, Rosenzwajg M, Carapito R, Shahrooei M, Konantz M, Khan A, et al. NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation. J Exp Med. 2020;217(12). 10.1084/jem.20192275. - PMC - PubMed
  90.  
    1. Wang L, Aschenbrenner D, Zeng Z, Cao X, Mayr D, Mehta M, et al. Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice. Nat Genet. 2021;53(4):500–510. doi: 10.1038/s41588-021-00803-4. - DOI - PMC - PubMed
  91.  
    1. Kanderova V, Svobodova T, Borna S, Fejtkova M, Martinu V, Paderova J, et al. Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK. J Allergy Clin Immunol. 2021. 10.1016/j.jaci.2021.07.046. - PubMed
  92.  
    1. de Jesus AA, Hou Y, Brooks S, Malle L, Biancotto A, Huang Y, et al. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. J Clin Invest. 2020;130(4):1669–1682. doi: 10.1172/JCI129301. - DOI - PMC - PubMed
  93.  
    1. Hegazy S, Marques MC, Canna SW, Goldbach-Mansky R, de Jesus AA, Reyes-Mugica M, et al. NEMO-NDAS: a panniculitis in the young representing an autoinflammatory disorder in disguise. Am J Dermatopathol. 2022. 10.1097/DAD.0000000000002144. - PMC - PubMed
  94.  
    1. Lee Y, Wessel AW, Xu J, Reinke JG, Lee E, Kim SM, et al. Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype. J Clin Invest. 2022;132(6). 10.1172/JCI128808. - PMC - PubMed
  95.  
    1. Kataoka S, Kawashima N, Okuno Y, Muramatsu H, Miwata S, Narita K, et al. Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor. J Allergy Clin Immunol. 2021;148(2):639–644. doi: 10.1016/j.jaci.2021.03.010. - DOI - PubMed
  96.  
    1. Kanazawa N, Hemmi H, Kinjo N, Ohnishi H, Hamazaki J, Mishima H, et al. Heterozygous missense variant of the proteasome subunit beta-type 9 causes neonatal-onset autoinflammation and immunodeficiency. Nat Commun. 2021;12(1):6819. doi: 10.1038/s41467-021-27085-y. - DOI - PMC - PubMed
  97.  
    1. Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020. 10.1056/NEJMoa2026834. - PMC - PubMed
  98.  
    1. Niihori T, Ouchi-Uchiyama M, Sasahara Y, Kaneko T, Hashii Y, Irie M, et al. Mutations in MECOM, encoding oncoprotein EVI1, cause radioulnar synostosis with amegakaryocytic thrombocytopenia. Am J Hum Genet. 2015;97(6):848–854. doi: 10.1016/j.ajhg.2015.10.010. - DOI - PMC - PubMed
  99.  
    1. Germeshausen M, Ancliff P, Estrada J, Metzler M, Ponstingl E, Rutschle H, et al. MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia. Blood Adv. 2018;2(6):586–596. doi: 10.1182/bloodadvances.2018016501. - DOI - PMC - PubMed
  100.  
    1. Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515). 10.1126/science.abd4585. - PMC - PubMed
  101.  
    1. Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021;6(62). 10.1126/sciimmunol.abl4340. - PMC - PubMed
  102.  
    1. Abers MS, Rosen LB, Delmonte OM, Shaw E, Bastard P, Imberti L, et al. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19. Immunol Cell Biol. 2021;99(9):917–921. doi: 10.1111/imcb.12495. - DOI - PMC - PubMed
  103.  
    1. Troya J, Bastard P, Planas-Serra L, Ryan P, Ruiz M, de Carranza M, et al. Neutralizing autoantibodies to type I IFNs in >10% of patients with severe COVID-19 pneumonia hospitalized in Madrid, Spain. J Clin Immunol. 2021;41(5):914–922. doi: 10.1007/s10875-021-01036-0. - DOI - PMC - PubMed
  104.  
    1. Solanich X, Rigo-Bonnin R, Gumucio VD, Bastard P, Rosain J, Philippot Q, et al. Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in Barcelona. J Clin Immunol. 2021;41(8):1733–1744. doi: 10.1007/s10875-021-01136-x. - DOI - PMC - PubMed
  105.  
    1. Koretzky GA, Abtahian F, Silverman MA. SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond. Nat Rev Immunol. 2006;6(1):67–78. doi: 10.1038/nri1750. - DOI - PubMed
  106.  
    1. Bellelli R, Boulton SJ. Spotlight on the replisome: aetiology of dna replication-associated genetic diseases. Trends Genet. 2021;37(4):317–336. doi: 10.1016/j.tig.2020.09.008. - DOI - PubMed
  107.  
    1. Chen YH, Spencer S, Laurence A, Thaventhiran JE, Uhlig HH. Inborn errors of IL-6 family cytokine responses. Curr Opin Immunol. 2021;72:135–145. doi: 10.1016/j.coi.2021.04.007. - DOI - PMC - PubMed
  108.  
    1. Lacruz RS, Feske S. Diseases caused by mutations in ORAI1 and STIM1. Ann N Y Acad Sci. 2015;1356:45–79. doi: 10.1111/nyas.12938. - DOI - PMC - PubMed
  109.  
    1. Yamashita M, Morio T. Inborn errors of IKAROS and AIOLOS. Curr Opin Immunol. 2021;72:239–248. doi: 10.1016/j.coi.2021.06.010. - DOI - PubMed
  110.  
    1. Duncan CJA, Hambleton S. Human disease phenotypes associated with loss and gain of function mutations in STAT2: viral susceptibility and type I interferonopathy. J Clin Immunol. 2021;41(7):1446–1456. doi: 10.1007/s10875-021-01118-z. - DOI - PMC - PubMed
  111.  
    1. Van Horebeek L, Dubois B, Goris A. Somatic variants: new kids on the block in human immunogenetics. Trends Genet. 2019;35(12):935–947. doi: 10.1016/j.tig.2019.09.005. - DOI - PubMed
  112.  
    1. Casanova JL, Holland SM, Notarangelo LD. Inborn errors of human JAKs and STATs. Immunity. 2012;36(4):515–528. doi: 10.1016/j.immuni.2012.03.016. - DOI - PMC - PubMed
  113.  
    1. Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370(6515). 10.1126/science.abd4570. - PMC - PubMed
  114.  
    1. Moens L, Meyts I. Recent human genetic errors of innate immunity leading to increased susceptibility to infection. Curr Opin Immunol. 2020;62:79–90. doi: 10.1016/j.coi.2019.12.002. - DOI - PubMed
  115.  
    1. Brehm A, Liu Y, Sheikh A, Marrero B, Omoyinmi E, Zhou Q, et al. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. J Clin Invest. 2015;125(11):4196–4211. doi: 10.1172/JCI81260. - DOI - PMC - PubMed

Page Navigation